Wed, 28 February 2018
The Cupertino company plans to open healthcare clinics that will rely heavily on its technology. Also, Gilead Sciences partners with Sangamo Therapeutics on gene-editing. Thanks to LegalZoom for supporting Motley Fool. Get special savings by going to legalzoom.com use code Fool at checkout. |